7th July 2026

Categories: FAQs

Why Have I Never Heard of Leiomyosarcoma Before?

Many people have never heard of Leiomyosarcoma until they are diagnosed. Learn why this rare cancer is less well known and why raising awareness is so important.

If you’ve recently been diagnosed with Leiomyosarcoma (LMS), one thought has probably crossed your mind:

“Why have I never heard of this before?”

You’re not alone.

In fact, it’s one of the most common reactions people have after receiving a diagnosis.

Unlike cancers such as breast, bowel or prostate cancer, Leiomyosarcoma is a rare cancer. Most people have never come across the name until it suddenly becomes part of their own lives or the life of someone they love.

What is Leiomyosarcoma?

Leiomyosarcoma is a rare type of soft tissue sarcoma that develops in smooth muscle tissue.

Smooth muscle is found throughout the body, which means Leiomyosarcoma can develop in different places, including the uterus, abdomen, blood vessels and other soft tissues.

Because it can occur in different parts of the body and often causes symptoms that can be associated with more common conditions, it isn’t always immediately recognised.

Why is it considered rare?

A cancer is generally described as rare when it affects a relatively small number of people compared with more common cancers.

Although thousands of people across the UK are living with rare cancers, each individual type is diagnosed much less frequently.

That means many healthcare professionals outside specialist teams may only see a small number of Leiomyosarcoma cases during their careers, while members of the public may never hear about it at all.

Why don’t we hear more about rare cancers?

Public awareness campaigns often focus on cancers that affect large numbers of people.

This is understandable, as these campaigns have an important role in encouraging early diagnosis and improving outcomes.

However, it can also mean that rarer cancers receive less attention, fewer conversations and less public understanding.

For people diagnosed with Leiomyosarcoma, this can sometimes add to the feeling of isolation.

Many patients say they struggled to find reliable information or meet anyone else who understood what they were going through.

Why awareness matters

Greater awareness can make a real difference.

When more people understand Leiomyosarcoma, it can help:

  • Encourage earlier conversations about unusual or persistent symptoms.
  • Improve understanding of rare cancers.
  • Support research into new treatments.
  • Help patients and families feel less alone.
  • Increase support for organisations working to improve outcomes.

Awareness isn’t about causing alarm. It’s about ensuring rare cancers are recognised, understood and given the attention they deserve.

Why Leiomyosarcoma Research UK was created

Leiomyosarcoma Research UK was founded because people directly affected by LMS recognised the need for a charity dedicated solely to this rare cancer.

The charity works to:

  • Improve awareness of Leiomyosarcoma.
  • Advance research into the disease.
  • Improve patient pathways.
  • Provide information and support for people affected by LMS and their families.

Every conversation, every shared experience and every research project helps build greater understanding of this rare cancer.

You are not alone

Although Leiomyosarcoma is rare, there is a growing community of patients, families, healthcare professionals, researchers and volunteers working together to improve the future for everyone affected by it.

If you’ve only just heard the word “Leiomyosarcoma”, it may feel as though you’ve been dropped into an unfamiliar world.

Take your time.

Ask questions.

Seek information from trusted sources.

And remember that there are people who understand what you’re going through and are working every day to improve awareness, research and support.

Related articles

Please remember: This article provides general information and should not replace advice from your healthcare team. If you have questions about your diagnosis or treatment, speak to your consultant or specialist sarcoma team.